The store will not work correctly when cookies are disabled.
1-{3-[4-(tert-butyl)phenyl]-5-N,N-dimethylamino-(1,2,4-triazol-4-yl)}-3-methoxybenzene
ID: ALA211673
PubChem CID: 10150089
Max Phase: Preclinical
Molecular Formula: C21H26N4O
Molecular Weight: 350.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(-n2c(-c3ccc(C(C)(C)C)cc3)nnc2N(C)C)c1
Standard InChI: InChI=1S/C21H26N4O/c1-21(2,3)16-12-10-15(11-13-16)19-22-23-20(24(4)5)25(19)17-8-7-9-18(14-17)26-6/h7-14H,1-6H3
Standard InChI Key: KMHZSWOKFAORBT-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
11.0468 -12.5125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7163 -12.0204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4532 -11.2342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6241 -11.2408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3736 -12.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4338 -12.4164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4487 -13.2424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1703 -13.6406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8775 -13.2140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8585 -12.3850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1364 -11.9905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0504 -13.3343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3371 -13.7509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3422 -14.5751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0599 -14.9837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7740 -14.5620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7654 -13.7392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4926 -14.9673 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6005 -13.6114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0083 -12.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1833 -14.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3214 -14.0127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2028 -14.5475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5909 -12.2920 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9737 -11.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4254 -13.1002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
6 7 2 0
13 14 1 0
1 2 1 0
14 15 2 0
7 8 1 0
15 16 1 0
3 4 1 0
16 17 2 0
17 12 1 0
1 12 1 0
8 9 2 0
16 18 1 0
4 5 2 0
9 19 1 0
9 10 1 0
19 20 1 0
5 1 1 0
19 21 1 0
10 11 2 0
19 22 1 0
11 6 1 0
18 23 1 0
2 6 1 0
5 24 1 0
2 3 2 0
24 25 1 0
24 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 350.47 | Molecular Weight (Monoisotopic): 350.2107 | AlogP: 4.31 | #Rotatable Bonds: 4 |
Polar Surface Area: 43.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.31 | CX LogP: 4.98 | CX LogD: 4.98 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.70 | Np Likeness Score: -1.56 |
References
1. Zhang Q, Keenan SM, Peng Y, Nair AC, Yu SJ, Howells RD, Welsh WJ.. (2006) Discovery of novel triazole-based opioid receptor antagonists., 49 (14): [PMID:16821764] [10.1021/jm0601250] |